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Myopericytoma Involving the Parotid
Gland as Depicted on Multidetector CT
Myopericytoma is a newly proposed subgroup of perivascular tumors in the
World Health Organization classification of soft tissue tumors. In this study, we
report a case of a benign myopericytoma with detailed multidetector CT (MDCT)
findings in the parotid gland, a location that has not been described for this type of
tumor previously. The clinical presentation, imaging features, histopathological
and immunohistochemical findings, and the differential diagnosis with other
tumors in the parotid gland are described and reviewed.
yopericytoma is an uncommon soft-tissue neoplasm characterized by a
perivascular proliferation of myoid differentiated pericytic cells (1). The
tumor generally arises within the subcutaneous tissue of the extremities
in middle-aged adults (2). Only a small number of cases of myopericytoma have been
reported in the clinical literature. In this report, we illustrate the CT features of a case
of a myopericytoma of the parotid gland. To the best of our knowledge, this is the first
reported case of this rare tumor that arose in a rare location of the head and neck.
CASE REPORT
A 41-year-old woman presented with a three-year history of a painless mass in the
region of the right parotid gland. A physical examination revealed a non-tender, firm
and slightly mobile mass without clear borders that was palpable in the right parotid
region. The overlying skin was indurated and warm. A clinical examination of the
neck revealed no lymphadenopathy. Facial nerve function of the patient was normal
on both sides.
CT of the maxillofacial region was performed using a 16-slice multidetector CT
(MDCT) scanner (Sensation 16, Siemens Medical Systems, Erlangen, Germany) with
unenhanced and enhanced scans. CT scanning was performed using parameters of 120
kV, 200 mAs and 5-mm collimation. An automatic injector was used to inject 90 mL
of Iopamiro into the antecubital vein at a rate of 3 mL/s. An unenhanced CT image
demonstrated the presence of a 5-cm round mass that was heterogeneous with central
lower density and showed a poorly defined margin without calcification or invasion of
the ambient structures in the superficial lobe of the right parotid gland (Fig. 1A). After
intravenous injection of contrast material, the mass demonstrated heterogeneous
attenuation with peripheral enhancement and central irregular non-enhancement. At
the periparotid areas, multiple, smooth margins and well-defined nodules with similar
CT features were demonstrated in the subcutaneous fat of the right cheek and
parapharyngeal spaces (Fig. 1B). No evidence of an abnormality was found by the use
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Mof chest radiograph and abdominal ultrasonography.
Surgical excision of the total right parotid gland and the
nodules at the periparotid areas were performed. All facial
nerve branches were preserved. The gross appearance of
the resected specimen for the large mass showed a tan-
colored, lobulated and solid tumor that measured 5.6 × 5.5
× 3 cm (Fig. 1C). A histopathological examination of the
mass showed many thin-walled branching vessels
surrounded by proliferative, relatively monomorphic oval-
to-spindle shaped myoid cells in the peripheral area, but
hyaline degeneration in the central area had no vessels (Fig.
1D, E). There were not malignant features such as nuclear
anaplasia, increased mitoses and infiltrative growth.
Immunohistochemical staining was positive for smooth
muscle actin (SMA) (Fig. 1F), but staining was negative for
CD34 (cluster of differentiation 34) and desmin. Based on
these findings, this tumor was diagnosed as a benign
myopericytoma that arose from the parotid gland. A
histopathological examination of the periparotid nodules
showed increased folliculus lymphaticus and proliferative
lymphocytes that did not contain tumor cells, which
indicated the presence of reactive lymphadenopathies.
The patient was alive without any discomfort as
examined during follow-up at nine months after surgical
excision of the mass. A follow-up CT examination
performed at nine months showed no evidence of any
residual or recurrent tumor in the right parotid gland
region.
DISCUSSION
Myopericytoma is a rare soft-tissue neoplasm with
perivascular differentiation of myoid cells. The term was
first proposed in 1996 by Requena et al. (4) and was
adopted in 1998 by McMenamin (3) to describe a spectrum
of tumors with striking concentric perivascular prolifera-
tion of spindle cells. Histological findings of myopericy-
toma are characterized by the presence of round or oval-
shaped cells with eosinophilic cytoplasm arranged circum-
ferentially around vascular lumina in a multilayered
pattern. Immunohistochemically, the tumor cells express
positive reactivity for SMA and muscle-specific actin.
Myopericytomas are usually benign. However, malignant
features such as necrosis, scattered pleomorphic tumors
and undifferentiated round-to-oval cells with local
recurrences and metastases have been also reported (1).
A benign myopericytoma can occur over a wide age
range from 10 to 87 years, with middle-aged male patient
predominance (2, 5). Benign myopericytomas are often
found in the dermis, subcutaneous tissue of the distal
extremities (hand, foot, ankle and leg) or neck (2).
Infrequently, tumors occur in the spine, intracranial cavity,
nose and nasal cavity, tongue and intravascular sites (6-
10). There are no relevant reports regarding a tumor
involving the parotid gland. A myopericytoma may be
single or may have multiple slow-growing nodules. The
lesions can exist for several years with or without pain, and
patients may have a succeeding appearance or impairment
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Fig. 1. Myopericytoma in parotid gland in 41-year-old woman.
A. Unenhanced CT scan shows 5-cm round mass with lower central density and poorly defined margin in superficial lobe of right parotid
gland (white arrow). Also note enlarged lymph nodes (arrowheads).
B. Contrast-enhanced CT scan shows peripheral enhancement (white arrow) and irregular central non-enhanced attenuation of mass.
Multiple reactive lymph nodes with similar CT features are also demonstrated in subcutaneous fat of right cheek and parapharyngeal
spaces (arrowheads). 
ABcaused by tumors. Patients with benign myopericytomas
are usually treated with surgical complete excision. Follow-
up shows a low incidence of local recurrence (2); the
prognosis of this entity is good. A malignant myopericy-
toma is extremely rare, often with local recurrence and
distant metastases in other organs or extensive metastases
(1).
A previous CT examination is rarely performed as this
type of tumor usually occurs in a superficial region. Harish
et al. (11) reported that a case of myopericytoma that
occurred in Kager’s fat pad showed a heterogeneous signal
with a small hyperintense focus as seen on a T1-weighted
image. After intravenous administration of gadolinium, the
majority of lesions showed intense enhancement except for
small hyperintense foci seen on unenhanced images, which
correspond to a surgical finding of hemorrhage. For the
present case, the peripheral hypervascular tissue had
enhancement that resulted from the sufficient blood
supply, whereas the central area within the mass showed
no enhancement that presumably resulted from hyaline
degenerated tissue without a blood supply.
The CT features of heterogeneous density, peripheral
contrast enhancement and unsmoothed margins are
nonspecific for a myopericytoma. The differential diagnosis
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Fig. 1. Myopericytoma in parotid gland in 41-year-old woman.
C. Resected specimen contains encapsulated, tan-colored tumor mass (straight arrow) surrounded by parotid glandular tissue (curved
arrow). 
D, E. Photomicrograph of histology specimen shows numerous thin-walled vessels surrounded concentrically by proliferative spindle-
shaped to oval-shaped myoid tumor cells in peripheral zone, as well as hyaline degeneration (E in black asterisks) in central zone
(Hematoxylin & Eosin staining, original magnification, ×200). 
F. Immunohistochemical staining shows positive reactivity for smooth muscle actin in tumor cells smooth muscle actin marker (original
magnification, ×400).
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should include some common and rare tumors in the
parotid gland, which have similar imaging manifestations.
Hemangiomas typically show progressive enhancement as
seen on dynamic contrast-enhanced CT images and
occasionally punctuated calcifications.
Hemangiopericytomas are usually manifested as well-
shaped soft tissue masses with homogeneous density or
signal intensity, as well as strong and homogeneous
enhancement as seen on CT or MRI. However, necrosis,
hemorrhage or focal calcifications are uncommon (12, 13).
For a mass in Kimura’s disease, T1- and T2-weighted
imaging usually shows a poorly defined outline, a hetero-
geneous internal structure (ranging from isointensity to
hyperintensity) and varying degrees of enhancement.
However, there are no characteristic findings on CT except
for the presence of a solid mass (14). Solitary fibrous
tumors are mostly well-defined and seen as isointense on
T1-weighted images, hyperintense as seen on T2-weighted
images and hypodense as seen on unenhanced CT images
as compared to the muscle, with intense heterogeneously
enhancement seen on CT and MRI (15, 16). Pleomorphic
adenomas and Warthin tumors are often well-defined
homogeneous masses, infrequently seen with cyst degener-
ation or necrosis. On a multi-phase enhanced CT scan,
pleomorphic adenomas usually show increased enhance-
ment on all phases. In contrast, Warthin tumors show peak
enhancement at 30 seconds and rapid reduction of
enhancement on delayed phases. However, malignant
tumors in the parotid gland show peak enhancement at 90
seconds (17, 18). These relatively specific features
demonstrated by CT and MR imaging may be useful in the
differential diagnosis of parotid gland tumors.
In conclusion, we report here the first documented case
of a myopericytoma involving the parotid gland, which
presented with heterogeneous density, peripheral contrast
enhancement and unsmoothed margins as seen on CT
images. Although the imaging features are nonspecific and
the diagnosis is still based on a pathological examination,
CT imaging is often required to demonstrate better the
margin and extent of the tumor.
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